WHO Announces Members Of Pandemic Influenza Advisory Group 21/11/2011 by William New, Intellectual Property Watch 1 Comment The World Health Organization today announced the 18 members of the advisory group that will monitor and report on implementation of the new WHO Pandemic Influenza Preparedness (PIP) Framework. The group started its first meeting today.
10 Years Of TRIPS And Public Health: An Anniversary To Celebrate? 21/11/2011 by Rachel Marusak Hermann, Intellectual Property Watch 4 Comments It has been 10 years since the World Trade Organization adopted the Doha Declaration on TRIPS and Public Health. The declaration highlighting the public health aspects of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreed at the 2001 WTO ministerial conference in Doha, Qatar was considered a milestone in ensuring greater access to medicines for all.
WHO Advisory Group On Pandemic Flu To Meet Next Week 17/11/2011 by Intellectual Property Watch Leave a Comment An advisory group on the new World Health Organization framework agreement on pandemic influenza preparedness is preparing to meet for the first time from 21-23 November.
WTO Ministers Asked To Send Message On TRIPS Extension For LDCs 17/11/2011 by Intellectual Property Watch 1 Comment The smallest countries in the World Trade Organization may get more time to comply with the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) after an agreement today.
WTO, WHO, WIPO To Discuss TRIPS And Health Declaration 17/11/2011 by Intellectual Property Watch Leave a Comment The heads of three international organizations in Geneva will address a meeting next week on the subject of 10 years after the Doha Declaration on TRIPS and Public Health. The 23 November symposium at the Graduate Institute in Geneva involves a range of top officials and experts on the issue.
Global Action To Open Generic Competition For Key AIDS Drug 16/11/2011 by Intellectual Property Watch 1 Comment Public health advocates in a dozen countries worldwide have launched a coordinated campaign to bring about generic competition on a key medicine for HIV/AIDS, currently under patent by a pharmaceutical producer.
CBO: Generics Bill Would Save US $4.8 Billion 09/11/2011 by Intellectual Property Watch Leave a Comment The US Congressional Budget Office has estimated that a current bill to prevent brand-name pharmaceutical companies from paying generic producers to delay the release of generic drugs into the market could save the US budget some $4.8 billion over 10 years. The bill would treat “pay-for-delay” arrangements as illegal and would give the authority to […]
Medicines Patent Pool Responds To Critics Of Gilead Licence 08/11/2011 by Intellectual Property Watch 1 Comment The Medicines Patent Pool, which aims to increase access to affordable, high-quality medicines for HIV/AIDS patients in low and middle income countries, has issued a response to concerns about its recent deal with a large pharmaceutical company.
WHO Board Backs Reform Plan For UN Agency 04/11/2011 by Intellectual Property Watch 1 Comment The UN World Health Organization Executive Board today approved a set of proposals for reform put forward by WHO Director General Margaret Chan and member states, authorising her to take immediate action. The WHO is undergoing a major reform process fueled by a funding shortage and changes in the global public health structure.
WHO’s Chan Pitches UN Agency’s “Staying Power,” Unique Role 01/11/2011 by William New and Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment World Health Organization Director General Margaret Chan today made a strident pitch to WHO member governments to invest in the well-known United Nations agency, citing several unique and essential aspects of the organisation. The WHO Executive Board is meeting this week to address major reform of the WHO, in part due to a severe funding shortage but reaching into its place in the global public health spectrum.